PharmX Technologies (ASX:PHX) Total Stockholders Equity : A$16.03 Mil (As of Dec. 2023)

View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Total Stockholders Equity?

PharmX Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$16.03 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PharmX Technologies's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PharmX Technologies's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.02.

PharmX Technologies Total Stockholders Equity Historical Data

The historical data trend for PharmX Technologies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Total Stockholders Equity Chart

PharmX Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

10.02

13.20

22.93

23.20

22.21

PharmX Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															23.05	23.20	22.68	22.21	16.03

PharmX Technologies (ASX:PHX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PharmX Technologies's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(16.029	-	0)	/	598.507
	=	0.03

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PharmX Technologies's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.102	+	0.188)	/	16.029
	=	0.02

PharmX Technologies Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmX Technologies (ASX:PHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000

Website

https://www.corumgroup.com.au

PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.